Canaan Vs. Akero Therapeutics Industry Stock Comparison

Sell

31

CAN
Canaan

Last Price:

$0.61

Seasonality Move:

-7.98%

Sell

50

AKRO
Akero Therapeutics

Last Price:

$54.14

Seasonality Move:

30.3%

Sell

31

Canaan (CAN) is a Sell

Is Canaan a Buy, Sell or Hold?

The current Canaan [CAN] share price is $0.61. The Score for CAN is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
CAN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Sell

50

Akero Therapeutics (AKRO) is a Sell

Is Akero Therapeutics a Buy, Sell or Hold?

The current Akero Therapeutics [AKRO] share price is $54.20. The Score for AKRO is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
AKRO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CAN Stock Price Chart

What is Canaan's stock price today?

The Canaan share price today is $0.61

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CAN is experiencing slight selling pressure.

AKRO Stock Price Chart

What is Akero Therapeutics's stock price today?

The Akero Therapeutics share price today is $54.20

The current trend is moderately bullish and AKRO is experiencing slight selling pressure.

CAN Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.02	Sell
Relative Strength Index (14 RSI):	42.18	Sell
Chaikin Money Flow:	-13231987	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(0.61 - 0.73)	Sell
Bollinger Bands (100):	(0.58 - 1.5)	Sell

AKRO Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	2.93	Buy
Relative Strength Index (14 RSI):	62.96	Buy
Chaikin Money Flow:	-901741	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(44.9 - 55.3)	Buy
Bollinger Bands (100):	(39.56 - 52.16)	Buy

CAN Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	0.68	Sell
20-day SMA:	0.65	Sell
50-day SMA:	0.7	Sell
200-day SMA:	1.31	Sell
8-day EMA:	0.65	Sell
20-day EMA:	0.67	Sell
50-day EMA:	0.76	Sell
200-day EMA:	1.18	Sell

AKRO Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	54.61	Sell
20-day SMA:	51.97	Buy
50-day SMA:	45.22	Buy
200-day SMA:	37.36	Buy
8-day EMA:	54.38	Sell
20-day EMA:	51.87	Buy
50-day EMA:	47.62	Buy
200-day EMA:	39.21	Buy

Canaan Earnings Growth & CAN Earnings Dates

Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.24 per share, an increase this year of $0.08 per share, and an increase next year of $0.65 per share.

Akero Therapeutics Earnings Growth & AKRO Earnings Dates

Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and a decrease next year of $0.64 per share.

Canaan Technical Analysis

	Jun 6	Jun 9	Jun 10	Jun 11	Jun 12	Jun 13	Jun 16	Jun 17	Jun 18	Jun 20
	Jun
	06	09	10	11	12	13	16	17	18	20
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Akero Therapeutics Technical Analysis

	Jun 6	Jun 9	Jun 10	Jun 11	Jun 12	Jun 13	Jun 16	Jun 17	Jun 18	Jun 20
	Jun
	06	09	10	11	12	13	16	17	18	20
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):